Summary
Hepatic metastasis from colorectal cancer is a common problem in clinical oncology. Results of new operative and chemotherapeutic techniques suggest that some patients may benefit from therapeutic intervention. However, phase II studies of these therapies often cannot adequately evaluate the impact of the natural history of the disease on the survival of the treated patient population. A review of the literature demonstrates that patients with hepatic metastases from colorectal cancer may survive for more than two years if they have favorable prognostic variables. Those factors that seem to have significant prognostic influence include resection of the primary tumor, nodal involvement at the time of primary surgery, presence or absence of extrahepatic disease, extent of hepatic involvement, abnormalities of liver function tests, and performance status. Classification schema that utilize these known prognostic variables are necessary to improve communication among investigators and our ability to evaluate new therapies as they are reported.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergtsson G, Carlsson G, Hafstrom L, Jonsson PE: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg Hi: 586–589, 1981.
Morris MO, Newland RC, Pherls MT, MacPherson JG: Hepatic metastases from colorectal carcinoma: An analysis of survival rates and histopathology. Aust NZ J Surg 363–368, 1977.
Bengmark S, Hafstrom L: The natural history of primary and secondary malignant tumors of the liver. Cancer 23: 198–202, 1969.
Oxley EM, Ellis H: Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 56: 149–152, 1969.
Bengmark S, Hafstrom L: The natural course for liver cancer. In: IM Ariel (ed). Progress in clinical cancer (VII). Grune & Stratton, New York, 1978, pp 195–199.
Silverman DT, Murray JL, Smart CR, Brown CC, Myers MH: Estimated median survival times of patients with colorectal cancer based on experience with 9,745 patients. Am J Surg 133: 289–293, 1977.
Cady B, Monson DO, Swinton NW: Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131: 697–700, 1970.
Lahr CJ, Soong SJ, Cloud G, Smith JW, Urist MM, Balch CM: A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal cancer. J Clin Oncol 1: 720–726, 1983.
Pestana C, Reitemeier RJ, Moertel CG, Judd ES, Dockerty MB: The natural history of carcinoma of the colon and rectum. Am J Surg 108: 826–829, 1964.
Abrahms MS, Lerner HJ: Survival of patients at Pennsylvania Hospital with hepatic metastases from carcinoma of the colon and rectum. Dis Colon Rectum 14: 431–434, 1971.
Jaffe BM, Donegan WL, Watson F, Spratt JS: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127: 1–11, 1968.
Bedikian AY, Chen TT, Malahy MA, Patt YZ, Bodey GP: Prognostic factors influencing survival of patients with advanced colorectal cancer: Hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases. J Clin Oncol 2: 174–179, 1984.
Goslin R, Steck G, Zamcheck N, Mayer R, Maclntyre J: Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25: 749–754, 1982.
Rapoport AH, Burleson RL: Survival of patients treated with systemic fluorouracil for hepatic metastases. Surg Gynecol Obstet 130: 773–777, 1970.
Flanagan L, Foster JH: Hepatic resection for metastatic cancer. Am J Surg 113: 551–557, 1967.
Foster JH, Berman MH: Resection of metastatic tumors. In: Solid liver tumors: Major problems in clinical surgery, Vol 22. WB Saunders, Philadelphia, 1977, pp 209–234.
Wagner JS, Adson MA, Van Heerden JA, Ilstrup DM: The natural history of hepatic metastases from colorectal cancer. Ann Surg 199: 502–507, 1984.
Petrelli NJ, Bonnheim DC, Herrera LO, Mittelman A: A proposed classification system for liver metastases from colorectal carcinoma. Dis Colon Rectum 27: 249–252, 1984.
Pettavel J, Morgenthaler F: Protracted arterial chemotherapy of liver tumors: An experience of 107 cases over a 12-year period. In: IM Ariel (ed). Progress in clinical cancer (VII). Grune & Stratton, New York, 1978, pp 217–233.
Wood CB, Gillis CR, Blumgart LH: A retrospective review of the natural history of patients with liver metastases from colorectal cancer, Clin Oncol 2: 285–288, 1976.
Nielsen J, Balslev I, Jensen HE: Carcinoma of the colon with liver metastases. Acta Chir Scand 137: 463–465, 1971.
Wanebo H: A staging system for liver metastases from colorectal cancer. (Abstract) Proc Am Soc Clin Oncol 2: 646, 1984.
Kim NK, Yasmineh WG, Freier EF, Goldman AI, Theologides A: Value of alkaline phosphatase, 5’-nucleotidase, Y -’glutamyltransferase, and glutamate dehydrogenase activity measurements (single and combined) in serum in diagnosis of metastasis to the liver. Clin Chem 23: 2034–2038, 1977.
Kemeny N, Braun D: Advanced colorectal carcinoma: Clinical and laboratory parameters as indicators of response and survival (Abstract). Proc Am Soc Clin Oncol 22: 336, 1981.
Lavin P, Mittelman A, Douglass H, Engstrom P, Klassen D: Survival and response to chemotherapy for advanced colorectal carcinoma. Cancer 46: 1536–1543, 1980.
Bonomi PD, Rossoff AH, Raynor WJ, Quadeer M: Prediction of survival duration in patients with metastatic measurable colorectal adenocarcinoma (Abstract). Proc Am Soc Clin Oncol 21: 161, 1980.
Van de Velde CJL, Sugarbaker PH: Liver Metastasis: Basic Aspects, Detection, and Management. In: Developments in Oncology, vol 24. Martinus Nijhoff, Boston, 1984, pp 383.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Haller, D.G. (1986). Prognostic Factors for Liver Metastases from Colorectal Cancer. In: Mastromarino, A.J. (eds) Biology and Treatment of Colorectal Cancer Metastasis. Developments in Oncology, vol 42. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2301-3_21
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2301-3_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9417-7
Online ISBN: 978-1-4613-2301-3
eBook Packages: Springer Book Archive